133 related articles for article (PubMed ID: 19229287)
41. [Anaerobic bacteria as a gene delivery system for breast cancer therapy].
Fujimori M
Nihon Rinsho; 2008 Jun; 66(6):1211-8. PubMed ID: 18540373
[TBL] [Abstract][Full Text] [Related]
42. Is there a role for nuclear factor kappaB in tumor necrosis factor-related apoptosis-inducing ligand resistance?
Plantivaux A; Szegezdi E; Samali A; Egan L
Ann N Y Acad Sci; 2009 Aug; 1171():38-49. PubMed ID: 19723036
[TBL] [Abstract][Full Text] [Related]
43. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.
Moriwaki K; Noda K; Furukawa Y; Ohshima K; Uchiyama A; Nakagawa T; Taniguchi N; Daigo Y; Nakamura Y; Hayashi N; Miyoshi E
Gastroenterology; 2009 Jul; 137(1):188-98, 198.e1-2. PubMed ID: 19361506
[TBL] [Abstract][Full Text] [Related]
44. Sensitization of human K562 leukemic cells to TRAIL-induced apoptosis by inhibiting the DNA-PKcs/Akt-mediated cell survival pathway.
Kim MJ; Kim HB; Bae JH; Lee JW; Park SJ; Kim DW; Park SI; Kang CD; Kim SH
Biochem Pharmacol; 2009 Sep; 78(6):573-82. PubMed ID: 19464267
[TBL] [Abstract][Full Text] [Related]
45. A quantitative method for measuring the antitumor potency of recombinant human endostatin in vivo.
Xu YF; Zhu LP; Hu B; Rong ZG; Zhu HW; Xu JM; Wu ZW; Wang JJ; Xu GX
Eur J Pharmacol; 2007 Jun; 564(1-3):1-6. PubMed ID: 17346697
[TBL] [Abstract][Full Text] [Related]
46. Preparation of selenium-enriched Bifidobacterium longum and its effect on tumor growth and immune function of tumor-bearing mice.
Yin Y; Wang RR; Wang Y; Wang JJ; Xu GX
Asian Pac J Cancer Prev; 2014; 15(8):3681-6. PubMed ID: 24870777
[TBL] [Abstract][Full Text] [Related]
47. Tumor-Targeting Therapy Using Gene-Engineered Anaerobic-Nonpathogenic Bifidobacterium longum.
Taniguchi S; Shimatani Y; Fujimori M
Methods Mol Biol; 2016; 1409():49-60. PubMed ID: 26846801
[TBL] [Abstract][Full Text] [Related]
48. Enhanced effects of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth, promoting apoptosis and inducing cell cycle arrest in vascular endothelial cells.
Li Y; Guo C; Wang Z; Gong P; Sun Z; Gong S
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):167-172. PubMed ID: 22528215
[TBL] [Abstract][Full Text] [Related]
49. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
50. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
Liang B; He ML; Chan CY; Chen YC; Li XP; Li Y; Zheng D; Lin MC; Kung HF; Shuai XT; Peng Y
Biomaterials; 2009 Aug; 30(23-24):4014-20. PubMed ID: 19427690
[TBL] [Abstract][Full Text] [Related]
51. Live bacteria as anticancer agents and tumor-selective protein delivery vectors.
Bermudes D; Zheng LM; King IC
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):194-9. PubMed ID: 11926125
[TBL] [Abstract][Full Text] [Related]
52. Arabinogalactan utilization in continuous cultures of Bifidobacterium longum: effect of co-culture with Bacteroides thetaiotaomicron.
Degnan BA; Macfarlane GT
Anaerobe; 1995 Apr; 1(2):103-12. PubMed ID: 16887514
[TBL] [Abstract][Full Text] [Related]
53. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
[TBL] [Abstract][Full Text] [Related]
54. Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition.
Sun HX; He HW; Zhang SH; Liu TG; Ren KH; He QY; Shao RG
Cancer Gene Ther; 2009 Sep; 16(9):693-702. PubMed ID: 19247395
[TBL] [Abstract][Full Text] [Related]
55. Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model.
Ismail M; Morgan R; Harrington K; Davies J; Pandha H
Cryobiology; 2009 Oct; 59(2):207-13. PubMed ID: 19646431
[TBL] [Abstract][Full Text] [Related]
56. Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.
Marini P; Budach W; Niyazi M; Junginger D; Stickl S; Jendrossek V; Belka C
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):198-202. PubMed ID: 19695436
[TBL] [Abstract][Full Text] [Related]
57. Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL).
Zauli G; Rimondi E; Celeghini C; Milani D; Secchiero P
J Cell Physiol; 2010 Feb; 222(2):357-64. PubMed ID: 19877156
[TBL] [Abstract][Full Text] [Related]
58. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
59. [Inhibition of liver tumor growth by combining endostatin gene delivery with radiotherapy].
Zheng AQ; Song XR; Yu JM; Wei L; Wang XW
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):309-10. PubMed ID: 15850527
[No Abstract] [Full Text] [Related]
60. Bifidobacteria and human health: regulatory effect of indigenous bifidobacteria on Escherichia coli intestinal colonization.
Romond MB; Haddou Z; Mielcareck C; Romond C
Anaerobe; 1997; 3(2-3):131-6. PubMed ID: 16887577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
